FIGURE 2.
Primary end points: MSSBP and LDL‐C changes at week 8. A, the least‐square mean values (LS Means, SE) of the MSSBP in the two (telmisartan/amlodipine 80/5 mg + rosuvastatin 20 mg and telmisartan 80 mg + rosuvastatin 20 mg) groups. B, the LS Means for LDL cholesterol reduction in the two (telmisartan/amlodipine 80/5 mg + rosuvastatin 20 mg and telmisartan/amlodipine 80/5 mg) groups